2017
DOI: 10.1590/0102-6720201700020003
|View full text |Cite
|
Sign up to set email alerts
|

Do the Radiological Criteria With the Use of Risk Factors Impact the Forecasting of Abdominal Neuroblastic Tumor Resection in Children?

Abstract: Background: The treatment of neuroblastoma is dependent on exquisite staging; is performed postoperatively and is dependent on the surgeon’s expertise. The use of risk factors through imaging on diagnosis appears as predictive of resectability, complications and homogeneity in staging. Aim: To evaluate the traditional resectability criteria with the risk factors for resectability, through the radiological images, in two moments: on diagnosis and in pre-surgical phase. Were analyzed the resectability, surgical … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 15 publications
0
3
0
Order By: Relevance
“…26 Of the studies included in the meta-analysis, five reported a single radiologist-interpreted images to determine the absence or presence of IDRFs, five reported using consensus reviews by a radiologist(s), surgeon(s), and oncologist(s), and the remainder did not describe how the presence of IDRFs was determined, providing no data on interobserver agreement. 4,9,[27][28][29][30][31][32][33][34][35][36][37][38][39][40][41] We found that regarding the presence or absence of IDRFs, a defining feature of L1 versus L2 disease, there was substantial variability in the frequency of reported IDRFs among radiologists for 50 patients (21-38 detected IDRFs on non-contrast examinations and 24-37 with contrast). Overall interobserver agreement on the binary presence or absence of IDRFs kappa = .5 [95% CI: .39-.61] without contrast and kappa = .63 [95% CI: .52-.75] with contrast.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…26 Of the studies included in the meta-analysis, five reported a single radiologist-interpreted images to determine the absence or presence of IDRFs, five reported using consensus reviews by a radiologist(s), surgeon(s), and oncologist(s), and the remainder did not describe how the presence of IDRFs was determined, providing no data on interobserver agreement. 4,9,[27][28][29][30][31][32][33][34][35][36][37][38][39][40][41] We found that regarding the presence or absence of IDRFs, a defining feature of L1 versus L2 disease, there was substantial variability in the frequency of reported IDRFs among radiologists for 50 patients (21-38 detected IDRFs on non-contrast examinations and 24-37 with contrast). Overall interobserver agreement on the binary presence or absence of IDRFs kappa = .5 [95% CI: .39-.61] without contrast and kappa = .63 [95% CI: .52-.75] with contrast.…”
Section: Discussionmentioning
confidence: 99%
“…A 2020 meta‐analysis concluded that IDRF‐positive patients have a significantly higher risk of incomplete resection (2.45 risk ratio), surgical complications (2.3 risk ratio), and worse event‐free survival (2.08 hazard ratio) and overall survival (2.44 hazard risk ratio) compared to IDRF‐negative patients 26 . Of the studies included in the meta‐analysis, five reported a single radiologist‐interpreted images to determine the absence or presence of IDRFs, five reported using consensus reviews by a radiologist(s), surgeon(s), and oncologist(s), and the remainder did not describe how the presence of IDRFs was determined, providing no data on interobserver agreement 4,9,27–41 . We found that regarding the presence or absence of IDRFs, a defining feature of L1 versus L2 disease, there was substantial variability in the frequency of reported IDRFs among radiologists for 50 patients (21–38 detected IDRFs on non‐contrast examinations and 24–37 with contrast).…”
Section: Discussionmentioning
confidence: 99%
“…The association of positive IDRFs at the time of initial diagnosis with poor outcome is a subject of controversy, with many authors suggesting that the IDRF status could change after chemotherapy, and as such, a new evaluation should be performed right before surgery, as it may have a different prognosis [ 19 , 20 , 21 , 22 ].…”
Section: Introductionmentioning
confidence: 99%